Euro RSCG Life to handle all new diabetes, thrombosis comms for Sanofi-Aventis

Share this article:
Sanofi-Aventis appointed Euro RSCG Life to handle all communications programs for all new diabetes and thrombosis drugs while renewing the network’s global assignments on Lovenox/Clexane, Lantus and Apidra, which the Havas network has handled since 2004. The firm also named Euro RSCG C&O to handle corporate communications.
Share this article:
You must be a registered member of MMM to post a comment.

Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.